Financials

News Discussions Technicals Forecast Seasonals

ZYUS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

ZYUS Life Sciences Corp. is a Canadian-based life sciences company. It focuses on the global development and commercialization of cannabinoid based pharmaceutical drug product candidates and exempt market therapeutics. The firm offers cGMP/EU GMP-compliant cannabinoid products to patients through the exempt global medical market. The company was founded by Zettl Harold Brent in April 2018 and is headquartered in Saskatoon, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

ZYUS does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company